Research study
GLP-1 Perception Deep Dive
Understanding how people feel about GLP-1 drugs through clones
- Who was asked
- US consumer clones, 900 clones
- When
- February 2026
- How
- Predicted responses from Brox clones, each built from a long-form interview with a real person, run on the Brox platform.
The full report GLP-1 Perception Deep Dive Open the report
Section 01: What the study found
- #
900
clones asked how likely they would be to try a GLP-1 at four monthly price points; even free barely moved the needle
base 900
Section 02: Where this sits
Ask this of your own customers: humans@brox.ai
More in Pharma & HCP
All in Pharma & HCP-
Veridian Oncology, an Invented Biotech: M&A Stress Test
18% peak-share assumption after the patient evidence, down from management's 30% (base 958)
Read -
GLP-1医薬品をDTC型で提供するオンライン診療モデルのSWOT分析
80.4% trust a doctor's recommendation over any other channel (base 528)
Read -
GLP-1 DTC Telehealth — SWOT Analysis
80.4% trust a doctor's recommendation over any other channel (base 528)
Read